Cas no for 145108-58-3,DEXMEDETOMIDINE HCL ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich

Post Sourcing Request Exhibition

Home > CAS No. Inquiry > 145108-58-3

[CAS Name] DEXMEDETOMIDINE HCL

[Formula] C13H17ClN2

Search Products Post Sourcing Request

[CAS Name]DEXMEDETOMIDINE HCL
[Alias]4-[(1r)-1-(2,3-dimethylphenyl)ethyl]-3h-imidazole hydrochloride ; 4-((s)-alpha,2,3-trimethylbenzyl)imidazole monohydrochloride ; DEXMEDETOMIDINE HYDROCHLORIDE ; DEMEDETOMIDINE HCL ; Dexmedetomidine(Pilot); ; 5-[(1R)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole hydrochloride (1:1); 5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole hydrochloride
[Number]145108-58-3
[EINECS]
[Formula]C13H17ClN2
[Molecular weight]236.7405

145108-58-3 Suppliers

Company

Main Products

Jiangsu Hengrui Medicine Co., Ltd.	Dexmedetomide HCl is an anxiolytic, sedative, andanalgesic medication. Similar to clonidine, it is an agonist of α2-adrenergic receptors in certain parts of the brain. Dexmedetomidine is notable for its ability to provide sedation without risk of respiratory depression (unlike other commonly used sedatives such as propofol, fentanyl, and midazolam) and can provide cooperative or semi-arousable sedation. Dexmedetomidine hydrochloride is also used in veterinary medicine for dogs and cats. For this API product, we have got Chinese local GMP certificate, and has US-DMF. For Dexmedetomide HCl Injection, we have got Chinese local GMP certificate, and US-ANDA has been submitted.	Send Inquiry
Jiangsu Nhwa Pharmaceutical Co., Ltd.	Anesthetics	Send Inquiry
Jiangsu Nhwa Pharmaceutical Co., Ltd.	Jiangsu Nhwa Pharmaceutical Corporation Ltd. is an integrated pharmaceutical corporation conducting technology, industry and distribution, and is the designated manufacturer of psychotropic drugs by National Ministry of Health.	Send Inquiry

Previous page 1 2 3 4 Next page

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us: About PharmaSources; Terms of Service; Privacy Policy; Event Data Sharing Notice; Intellectual Property; Media Partners

PharmaSources Customer Service